Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight

Positive

AI Analysis

Summary

DelveInsight report forecasts the oncology-based in-vivo CRO market will grow at approximately 8% CAGR through 2034, driven by increasing cancer prevalence and pharmaceutical companies' demand for outsourced preclinical oncology research.

Importance:2/10

Sentiment:

0.30

market analysisoncologyCROpreclinical researchoutsourcing

Related Companies

$DFPH $GMRE-PA

Read the original article

Published by PR Newswire Biotech on July 1, 2026 2:46 PM

Read Original